Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000214430 | SCV000271162 | likely benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | Glu541Glu in Exon 09 of USH2A: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 1/7020 European Ameri can chromosomes from a broad population by the NHLBI Exome Sequencing Project (h ttp://evs.gs.washington.edu/EVS; dbSNP rs146805130). |
Counsyl | RCV000664772 | SCV000788783 | likely benign | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2017-01-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000919466 | SCV001064812 | likely benign | not provided | 2024-10-19 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454582 | SCV004182514 | likely benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454581 | SCV004182515 | likely benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000214430 | SCV005184956 | likely benign | not specified | 2024-05-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000919466 | SCV005263724 | likely benign | not provided | criteria provided, single submitter | not provided |